June 7, 2018
FDA issues Class I Recall of CARDIOSAVE Hybrid Intra-aortic Balloon Pump by Maquet Datascope
Editor's Note
The Food & Drug Administration on June 6 identified the recall by Maquet Datascope Corp of its CARDIOSAVE Hybrid Intra-aortic Balloon Pump as Class I, the most serious.
The recall was initiated because of a design issue that allows fluid to seep into the device, which can lead to device malfunction and serious adverse health consequences, including death.
Manufacturing dates were December 12, 2011 to April 25, 2018. Distribution dates were March 6, 2012 to April 26, 2018.
Free Daily News
- Hospital, health system mergers reach new heights
- Algorithm enhances decision-making on intermediate-stage liver cancer surgery, treatment
- Hispanic Heritage Month reports highlight awareness, action on organ transplant disparities
- Medicare policy on prior authorization falls short on shifting outpatient surgery trends
- DEA registration validation changes challenge healthcare accreditation
- CMS proposes $2 Drug List Model to reduce out-of-pocket costs for Medicare recipients
- Algorithm enables continuous forecasting of intraoperative blood pressure
- Study: Improper arm positioning during blood pressure measurements can lead to hypertension overdiagnosis
- JAMA video highlights OR sustainability
- AAP releases first opioid prescribing guidelines for children
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement